Piramal collaborates with BerGenBio to develop leukemia treatment
The collaboration will be focused on the development of bemcentinib for the treatment of elderly patients with relapsed Acute…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
CDMO
Piramal’s Pharma business grows over 10 per cent in FY19
Growth is attributed to revenues derived from niche businesses of complex generics and Contract Development and Manufacturing…
Piramal Pharma invests $10 million to expand its high potency API capability in US
Expansion enhances the company’s ability to serve the growing ADC market
Piramal Pharma Solutions (PPS), a leading Contract…
‘There will be a shakeout in the CDMO industry’
Swedish Recipharm has been on an acquisition spree, buying out Italian CDMO, Mitim Srl in February, and completing acquisition of…
Recipharm to acquire Kemwell’s CDMO biz
Signs two separate strategic agreements in India, US and Sweden
Recipharm has signed two separate agreements to acquire Kemwell’s…